Speaker: 

Dominick Patafio, PharmD., PGY1 Pharmacy Resident, Geisinger Medical Center - has nothing to disclose.

Moderator: 

Sarah F. Hale, PharmD., BCPPS; Director of Pharmacy, Geisinger Medical Center - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the epidemiology of acute ischemic stroke in the United States
• Identify risk factors related to acute ischemic stroke.
• Compare the data describing the place of therapy of antithrombotic agents in acute ischemic stroke.
• Determine the effect of delayed Tenecteplase therapy on functional outcomes in large-vessel stroke with salvageable ischemic brain tissue.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD; Brain Simpkins, PharmD; Jessica Milheim, CPhT and Nichole Varela Gonzalez, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.